| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.3M | -46.5% |
| Cost of Revenue | $10.6M | -36.5% |
| Gross Profit | $125.8M | -24.9% |
| R&D Expense | $20.7M | +114.8% |
| SG&A Expense | $266.9M | +124.2% |
| Operating Income | -$346.0M | -314.9% |
| Pre-tax Income | -$374.0M | -413.7% |
| Income Tax | $26K | +2700.0% |
| Net Income | -$374.1M | -413.8% |
| EPS (Basic) | -$36.48 | -6414.3% |
| EPS (Diluted) | -$36.48 | -5880.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | +51.4% |
| Accounts Receivable | $15.2M | -42.3% |
| Inventory | $4.8M | +96.6% |
| Current Assets | $38.4M | -7.7% |
| Total Assets | $365.0M | +292.7% |
| Current Liabilities | $483.7M | +86.3% |
| Total Liabilities | $576.7M | +101.9% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.8M | -80.3% |
| Capital Expenditures | $133K | — |
| Investing Cash Flow | $4.1M | +252.7% |
| Financing Cash Flow | -$5.5M | +69.9% |
| Free Cash Flow | $3.7M | -81.0% |
| -$207.8M |
| -7.9% |